PT Bio Farma

Related records

Trials (48)

• A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations
• Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine
• Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
• Clinical Trial of Novel OPV2 Vaccine
• Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B
• Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)
• Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients
• Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
• Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine
• Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)
• Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age
• Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
• Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine
• Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)
• Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
• Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
• Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine
• Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
• Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV
• Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)